To characterize the predictive value of inflammatory plasma biomarkers in post-stroke seizures (PSS) risk and functional outcomes in PSS risk patients at 1-year follow-up.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: